CD8A and non-small cell lung carcinoma: For example, the immunoscore was proposed based on the density of stromal CD8+ TILs and has been validated as a risk assessment tool in resected NSCLC, highlighting the potential importance of evaluating the immune infiltrate of tumor in guiding decision-making in the clinic (10).